文献速递间质性肺疾病

二氧化氮增加特发性肺纤维化疾病进展风险

Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis.
PubMed 文献 · Respirology · 2022-09-19

该研究分析946例特发性肺纤维化(IPF)患者的系列肺功能数据,利用全国尺度暴露预测模型估算个体长期NO2和PM10暴露。中位随访1.0年期间57.8%患者出现进展,NO2浓度每增加10-ppb与进展风险增加10.5%相关(HR=1.105,95%CI=1.000-1.219),而PM10与进展无关联。

要点

  • 个体NO2长期暴露每增加10-ppb,IPF进展风险增加10.5%。
  • NO2暴露第二至第四分位较第一分位呈现进展风险递增趋势。
  • PM10暴露与IPF疾病进展无显著关联。

核心结论

  • 个体NO2暴露增加可提高IPF患者疾病进展风险。
  • PM10暴露与IPF疾病进展无关联。

研究设计与样本

  • 分析946例IPF患者的系列肺功能数据,平均年龄65.4岁,男性占80.9%。
  • 采用基于空气质量监管监测数据构建的全国尺度暴露预测模型估算个体长期NO2和PM10住宅暴露。
  • 进展定义为用力肺活量相对下降≥10%。
  • 主要分析模型调整个体和地区层面协变量。

主要发现

  • 中位随访1.0年(四分位距0.4-2.6年)期间547例(57.8%)患者发生进展。
  • NO2浓度每增加10-ppb与进展风险增加10.5%相关(HR=1.105;95%CI=1.000-1.219)。
  • NO2第二分位HR=1.299(95%CI=0.972-1.735),第三分位HR=1.409(95%CI=1.001-1.984),第四分位HR=1.598(95%CI=1.106-2.310),均以第一分位为参照。
  • PM10与IPF患者进展无关联。

临床怎么用

  • 对IPF患者应关注其NO2暴露水平,作为疾病进展风险评估的参考因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Air pollution affects clinical course and prognosis of idiopathic pulmonary fibrosis (IPF). However, the effect of individual exposure to air pollutants on disease progression is unclear. We aimed to identify the effect of individual exposure to nitrogen dioxide (NO2 ) and particulate matter (aerodynamic diameter ≤ 10 μm [PM10 ]) on disease progression in patients with IPF. METHODS: The serial lung function data of 946 IPF patients (mean age: 65.4 years, male: 80.9%) were analysed. Individual-level long-term exposures to NO2 and PM10 at the residential addresses of patients were estimated using a national-scale exposure prediction model, constructed based on air quality regulatory monitoring data. Progression was defined as a relative decline (≥10%) in forced vital capacity. Individual- and area-level covariates were adjusted in the primary analysis model. RESULTS: Overall, 547 patients (57.8%) experienced progression during a median follow-up of 1.0 year (interquartile range: 0.4-2.6 years). In the primary model, a 10-ppb increase in NO2 concentration was associated with a 10.5% increase in the risk of progression (hazard ratio [HR] = 1.105; 95% CI = 1.000-1.219) in patients with IPF. There was also an increasing trend of progression in patients with IPF according to the second to fourth quartiles of NO2 (Q2 [HR = 1.299; 95% CI = 0.972-1.735], Q3 [1.409; 1.001-1.984], Q4 [1.598; 1.106-2.310]) compared to the first quartile. We found no association between PM10 and progression in IPF patients. CONCLUSION: Our data suggest that increased individual exposure to NO2 can increase the risk of progression in patients with IPF.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Yoon HY, Kim SY, Kim OJ, et al. Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis. Respirology. 2022. PMID: 36123769. doi:10.1111/resp.14373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。